InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
10
T+90 hit rate
19%
T+90 mean return
-15.4%
Across 16 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Monahan Joseph, Directeur Scientifique. Insider active across 1 company, notably Aclaris Therapeutics, Inc.. In total, 26 reports have been logged. Breakdown: 0 buy · 10 sells. Total volume traded: €1.2m. Activity tracked since 9 February 2022. The latest transaction was filed on 1 February 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations26 total
50,000 sharesCommon StockSEC:0001415889-25-006495:0
7,500 sharesCommon StockSEC:0001415889-25-002940:0
14,750 sharesCommon StockSEC:0001415889-25-002940:1
11,317 shares@ US$2.482.2% of flowCommon StockSEC:0001415889-25-002940:2
73,750 sharesCommon StockSEC:0001415889-25-000624:0
15,000 shares0Common StockSEC:0001415889-24-029092:0
50,000 sharesCommon StockSEC:0001209191-24-004402:0
7,500 sharesCommon StockSEC:0001209191-24-002840:0
6,000 shares@ US$5.07672.3% of flowCommon StockSEC:0001209191-23-053558:0
6,000 shares@ US$7.31583.3% of flowCommon StockSEC:0001209191-23-046905:0
6,000 shares@ US$10.27714.6% of flowCommon StockSEC:0001209191-23-039070:0
13,750 sharesCommon StockSEC:0001209191-23-016065:0
5,000 shares@ US$13.06215.0% of flowCommon StockSEC:0001209191-23-010658:0
5,000 shares@ US$15.88236.1% of flowCommon StockSEC:0001209191-22-061695:0
5,000 shares@ US$15.98156.7% of flowCommon StockSEC:0001209191-22-054073:0
30,000 shares@ US$16.27660.072% mcap53.5% of flowCommon StockSEC:0001209191-22-025032:0
27,165 shares@ US$15.71150.061% mcap45.5% of flowCommon StockSEC:0001209191-22-018501:0
13,750 sharesCommon StockSEC:0001209191-22-015829:0
383 shares@ US$12.68180.0007% mcap0.5% of flowCommon StockSEC:0001209191-22-008860:0
383 shares@ US$12.68180.0007% mcap100.0% of flowCommon StockSEC:0001209191-22-008860
1,050 sharesCommon StockSEC:0001209191-22-006836
1,050 sharesCommon StockSEC:0001209191-22-006836:0
2,333 sharesCommon StockSEC:0001209191-21-054530
2,333 sharesCommon StockSEC:0001209191-21-054530:0
50,000 sharesCommon StockSEC:0001209191-21-037478
25 of 26 declarations
About Monahan Joseph
Joseph Monahan is Chief Scientific Officer at Aclaris Therapeutics, Inc. He is responsible for leading the company's research and development initiatives, contributing to innovation and product advancement. His scientific expertise is essential for guiding research projects and ensuring compliance with industry regulations. Through his leadership, he plays a key role in the development of therapeutic solutions.
